Morepen Laboratories Ltd

NSE: MOREPENLAB · BSE: 500288 · Pharmaceuticals & Biotechnology · 10 announcements

Share price: ₹120.38
Market cap: ₹6,596 Cr
Revenue (annual): ₹1,806 Cr
Net profit (annual): ₹94.88 Cr
P/E (TTM): 46.9×Sector 50.4×
Promoter holding: 35.65%+0.00% QoQ
FII holding: 1.46%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 3 Financial Results 2 Earnings Call 2 Production Started 1 Other Announcement 1 New Order Win 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

2 Sep 2026 13:14 IST BSE

New Order WinAlfa Alert

Morepen Laboratories Bags ₹825 Cr Order from Leading global pharmaceutical company

Morepen Laboratories secured a multi-year CDMO mandate worth approximately ₹825 Crore from a global pharmaceutical firm. This represents one of the largest single mandates in the company's history.

Value: ₹825.0 Cr
From: Leading global pharmaceutical company
Execution: Multi-year

Read the filing ↗